Beckman Coulter has been awarded with Frost & Sullivan‘s 2020 Global New Product Innovation Award for Beckman’s DxH 690T hematology analyzer. The analyzer provides superior technology while identifying cell types and providing faster, reliable assessments for clinical decision making.
Beckman Coulter’s DxH 690T Hematology Analyzer streamlines automation and workflow. The Analyzer provides an industry leading 93% first-pass yield for hematology analysis and features support for the Early Sepsis Indicator (ESId) hematology biomarker for sepsis.
With staff shortages and financial strains, the DxH 690T is designed for medium sized hospitals and mid-volume laboratories. The analyzer maintains many features that the high-volume analyzers provide, while being less of a financial burden.